HYALASE

This brand name is authorized in Hong Kong, Israel, Malta, New Zealand, Singapore

Active ingredients

The drug HYALASE contains one active pharmaceutical ingredient (API):

1 Hyaluronidase ovine UNII 64R4OHP8T0 - HYALURONIDASE (OVINE)

Hyaluronidase is an enzyme that has a temporary and reversible depolymerising effect on the polysaccharide hyaluronic acid, which is present in the intercellular matrix of connective tissue. Read about Hyaluronidase

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
HYALASE Powder for solution for injection/infusion	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B06AA03	Hyaluronidase	B Blood and blood forming organs → B06 Other hematological agents → B06A Other hematological agents → B06AA Enzymes
Discover more medicines within B06AA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: HK	Department of Health Drug Office	Identifier(s): 35245
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8615
Country: MT	Medicines Authority	Identifier(s): MA143/07201
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 2784
Country: SG	Health Sciences Authority	Identifier(s): 10302P